Skip to content
Brand Protocol

Allergy Research Group – Healthy Kids*

Upload template
Protocols Brand Protocols Allergy Research Group
Allergy Research Group – Healthy Kids*

Children’s Multi-Vi-Min®

As a dietary supplement, for children 1 through 3 years of age, 1 capsule daily mixed into food or beverage; 4 through 7 years, 2 to 4 capsules daily with food; 8 years and older, 3 to 6 capsules daily with food, or as directed by your healthcare practitioner

Small capsule (size 3) for easy swallowing, suitable for children, and for adults who have problems swallowing capsules. Now with vitamins C, K1 and K2, potassium iodide, increased vitamin D3, and active forms of vitamins B2, B6, B12, and folate as Quatrefolic®.

DHA

Take 1 softgel daily with meals, or as directed by a healthcare practitioner

Provides Friend of the Sea (FOS) and Marine Ingredients Organization for Responsible Supply (IFFO RS) certified omega-3 fatty acids DHA and EPA. 200 mg of EPA and 160 mg of DHA per softgel.

Phospholipid Colostrum Powder

Mix 1 scoop (5 g) with liquid or semi-liquid substance and take once daily, or as directed by a healthcare professional

Colostrum obtained solely from United States Grade-A dairies, free of antibiotics and growth hormones, coated with sunflower-sourced phospholipids for bioavailability enhancement.* Colostrum supports normal gut integrity and provides immunoglobulins and other factors that support normal, healthy immune system function.*

For additional support, consider:

Liposomal Melatonin

Take 1 pump by mouth, hold for 30 seconds before swallowing, or as directed by a healthcare practitioner

Fast-acting melatonin liquid with liposomal delivery for improved bioavailability and prolonged retention in the body, supporting a normal melatonin cycle through the night.*

Liposomal Zen®

Take 1 to 4 pumps taken orally one or two times daily between meals, or as directed by a healthcare practitioner

Advanced liquid liposomal version of the product, 200 mg of Zen, containing GABA, L-theanine, and sunflower phospholipids.

Disclaimer

The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.

Upload template

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.